BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24475024)

  • 1. Traceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivo.
    Prill JM; Subr V; Pasquarelli N; Engler T; Hoffmeister A; Kochanek S; Ulbrich K; Kreppel F
    PLoS One; 2014; 9(1):e82716. PubMed ID: 24475024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting.
    Jönsson F; Hagedorn C; Kreppel F
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30417881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifications of adenovirus hexon allow for either hepatocyte detargeting or targeting with potential evasion from Kupffer cells.
    Prill JM; Espenlaub S; Samen U; Engler T; Schmidt E; Vetrini F; Rosewell A; Grove N; Palmer D; Ng P; Kochanek S; Kreppel F
    Mol Ther; 2011 Jan; 19(1):83-92. PubMed ID: 20959811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity.
    Krutzke L; Prill JM; Engler T; Schmidt CQ; Xu Z; Byrnes AP; Simmet T; Kreppel F
    J Control Release; 2016 Aug; 235():379-392. PubMed ID: 27302248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capsomer-specific fluorescent labeling of adenoviral vector particles allows for detailed analysis of intracellular particle trafficking and the performance of bioresponsive bonds for vector capsid modifications.
    Espenlaub S; Corjon S; Engler T; Fella C; Ogris M; Wagner E; Kochanek S; Kreppel F
    Hum Gene Ther; 2010 Sep; 21(9):1155-67. PubMed ID: 20384482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductive amination as a strategy to reduce adenovirus vector promiscuity by chemical capsid modification with large polysaccharides.
    Espenlaub S; Wortmann A; Engler T; Corjon S; Kochanek S; Kreppel F
    J Gene Med; 2008 Dec; 10(12):1303-14. PubMed ID: 18837065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide.
    Kreppel F; Kochanek S
    Mol Ther; 2008 Jan; 16(1):16-29. PubMed ID: 17912234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting.
    Li L; Yang Q; Zhou Z; Zhong J; Huang Y
    Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation into the Biological Impact of Block Size on Cathepsin S-Degradable HPMA Copolymers.
    Fan W; Zhang W; Jia Y; Brusnahan SK; Garrison JC
    Mol Pharm; 2017 May; 14(5):1405-1417. PubMed ID: 28263073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers.
    Oupický D; Konák C; Ulbrich K; Wolfert MA; Seymour LW
    J Control Release; 2000 Mar; 65(1-2):149-71. PubMed ID: 10699278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control.
    Schmid M; Ernst P; Honegger A; Suomalainen M; Zimmermann M; Braun L; Stauffer S; Thom C; Dreier B; Eibauer M; Kipar A; Vogel V; Greber UF; Medalia O; Plückthun A
    Nat Commun; 2018 Jan; 9(1):450. PubMed ID: 29386504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced intracellular and intranuclear drug delivery mediated by biomimetic peptide SVS-1 for anticancer therapy.
    Xiang Y; Chen L; Zhou R; Huang Y
    Int J Pharm; 2019 Oct; 570():118668. PubMed ID: 31494237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term biodistribution study of HPMA-ran-LMA copolymers in vivo by means of
    Wagener K; Moderegger D; Allmeroth M; Reibel A; Kramer S; Biesalski B; Bausbacher N; Zentel R; Thews O; Rösch F
    Nucl Med Biol; 2018 Mar; 58():59-66. PubMed ID: 29413458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of tailor-made copolymers of oligo(ethylene glycol) methyl ether methacrylate and N,N-dimethylaminoethyl methacrylate as nonviral gene transfer agents: influence of macromolecular structure on gene vector particle properties and transfection efficiency.
    Uzgün S; Akdemir O; Hasenpusch G; Maucksch C; Golas MM; Sander B; Stark H; Imker R; Lutz JF; Rudolph C
    Biomacromolecules; 2010 Jan; 11(1):39-50. PubMed ID: 19957957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.
    Sen D; Gadkari RA; Sudha G; Gabriel N; Kumar YS; Selot R; Samuel R; Rajalingam S; Ramya V; Nair SC; Srinivasan N; Srivastava A; Jayandharan GR
    Hum Gene Ther Methods; 2013 Apr; 24(2):104-16. PubMed ID: 23442071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
    Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
    Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates.
    Yang Y; Zhou Z; He S; Fan T; Jin Y; Zhu X; Chen C; Zhang ZR; Huang Y
    Biomaterials; 2012 Mar; 33(7):2260-71. PubMed ID: 22189143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactosylated N-2-hydroxypropyl methacrylamide-b-N-3-guanidinopropyl methacrylamide block copolymers as hepatocyte-targeting gene carriers.
    Qin Z; Liu W; Li L; Guo L; Yao C; Li X
    Bioconjug Chem; 2011 Aug; 22(8):1503-12. PubMed ID: 21688826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cells.
    David A; Kopecková P; Kopecek J; Rubinstein A
    Pharm Res; 2002 Aug; 19(8):1114-22. PubMed ID: 12240936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charge-Reversible Multifunctional HPMA Copolymers for Mitochondrial Targeting.
    Wang F; Sun W; Li L; Li L; Liu Y; Zhang ZR; Huang Y
    ACS Appl Mater Interfaces; 2017 Aug; 9(33):27563-27574. PubMed ID: 28762267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.